2024-10-23 19:35:27
Asieris Obtained IND Approval from US FDA for APL-1401, a New Drug for the Treatment of Moderately-to-Severely Active Ulcerative Colitis
Health/ 2023-07-22
Asieris Obtained IND Approval from US FD...

SHANGHAI,Nov. 10,2022--Asieris Pharmaceuticals (688176),a global biopharma company specializing in discovering,developing and commercializin...

Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
Health/ 2023-07-22
Prenetics Announces Record Third Quarter...

LONDON and HONG KONG,Nov. 10,2022-- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"),a global leade...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release